Related Experiment Video

Updated: Apr 4, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.1K

Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway

Elena López-Isac1, Diana Campillo-Davo1, Lara Bossini-Castillo1

  • 1Institute of Parasitology and Biomedicine López-Neyra, IPBLN-CSIC, PTS Granada, Granada, Spain.

Annals of the Rheumatic Diseases
|September 5, 2015
PubMed
Abstract

Insights

This study links the TYK2 gene to systemic sclerosis (SSc), a common autoimmune disease. Our findings highlight the crucial role of the TYK2 gene and the interleukin-12 pathway in SSc development.

Area of Science:

  • Immunogenetics
  • Rheumatology
  • Molecular Biology

Background:

  • Tyrosine kinase 2 (TYK2) is implicated in autoimmune diseases.
  • The interleukin-12 (IL-12) pathway is a key factor in systemic sclerosis (SSc) pathogenesis.
  • Genetic variations in TYK2 may influence SSc susceptibility.

Purpose of the Study:

  • To investigate the association between TYK2 gene variants and systemic sclerosis (SSc).
  • To explore the role of the TYK2 locus in the pathophysiology of SSc.

Main Methods:

  • A case-control study involving 7103 SSc patients and 12,220 healthy controls of European ancestry.
  • Analysis of four TYK2 single-nucleotide polymorphisms (SNPs): V362F, P1104A, I684S, and A928V.
  • Statistical analyses included logistic regression, conditional logistic regression, and meta-analyses using the inverse variance method.

Main Results:

  • The common TYK2 V362F variant showed genome-wide significant association with SSc (p=3.08×10⁻¹³).
  • Rare missense variants (P1104A, A928V, I684S) also demonstrated significant nominal associations.
  • Allelic combination analyses revealed that the V362F association was synthetic, driven by the effects of the other three missense variants.

Conclusions:

  • This study establishes, for the first time, a significant association between TYK2 and systemic sclerosis (SSc).
  • The findings underscore the importance of the IL-12 pathway in SSc pathophysiology.
  • Genetic variations in TYK2 represent a risk factor for SSc.
Keywords:
CytokinesGene PolymorphismSystemic SclerosisTreatment

More Related Videos

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.7K
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

25.0K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.0K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
112
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
68
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.7K
Epistasis01:39

Epistasis

In addition to multiple alleles at the same locus influencing traits, numerous genes or alleles at different locations may interact and influence phenotypes in a phenomenon called epistasis. For example, rabbit fur can be black or brown depending on whether the animal is homozygous dominant or heterozygous at a TYRP1 locus. However, if the rabbit is also homozygous recessive at a locus on the tyrosinase gene (TYR), it will have an unshaded coat that appears white, regardless of its TYRP1...
51.3K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.3K